Harbin Pharmaceutical Group Co., Ltd.SSE: 600664

(600664)"Harbin Pharmaceutical Group Co., Ltd."Report for Q3 2026

Oct 27, 2026 · Issued by Harbin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600664 · Oct 27, 2026

On 6ix: 6ix.com/news/600664harbin-pharmaceutical-group-co-ltdreport-for-q3-2026

Report for Q3 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix is reading this filing.

View original source (Shanghai Stock Exchange)Harbin Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Harbin Pharmaceutical

(600664)"Harbin Pharmaceutical Group Co., Ltd."Announcement on the Affiliated Enterprise's Receipt of the Approval Notice for the Marketing Application of a Chemical APIOct 13
Announcement on Imposition of Detention Measures on a Director and Senior ExecutiveOct 12
Semi-annual Report for 2026Aug 26
Announcement on Abnormal Fluctuations in Stock TradingAug 12
Announcement on the Proposed Selection in the 12th Batch of National Centralized Drug ProcurementAug 4

All Harbin Pharmaceutical news releases

Follow Harbin Pharmaceutical into a list and get an email when it puts out news.

Follow Harbin Pharmaceutical